Company Directory > CDMO > Batavia Biosciences
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Batavia Biosciences and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Batavia Biosciences is a global Contract Development and Manufacturing Organization (CDMO) specializing in the development and manufacturing of viral vectors, vaccines, and recombinant proteins. The company focuses on accelerating the translation of innovative therapies from research to clinical and commercial stages, aiming to reduce costs and timelines for biopharmaceutical partners. They offer a suite of proprietary technology platforms, including STEP®, SCOPE®, SIDUS®, SCOUT®, and SATIRN®, designed to improve product yield, process development speed, and product stability. With facilities in the Netherlands and the United States, Batavia Biosciences supports a diverse range of clients, including big pharma, biotech companies, academia, and non-profit organizations.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:
Industry:CDMO
Sub-Industry:Viral vectors, vaccines, and recombinant proteins
SIZE & FINANCIALS
Employees:201-500
Founded:2010
Ownership:private
Status:operating
PIPELINE
Stage:N/A
Lead Drug Stage:N/A
Modalities:Viral vectors, Vaccines, Recombinant proteins
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:VBC and MEVAC (Vaccine manufacturing in Egypt)
COMPETITION
Position:Niche Player
Competitors:Lonza, Catalent, Thermo Fisher Scientific (Patheon), WuXi Biologics
LEADERSHIP
Key Executives:
Wilfried Bakker - CEO/Founder
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Batavia Biosciences. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.